Fumaric Acid

Fumaric Acid

SCHEMBL9499394

CCSc1ccc(OC(CCNC)c2ccccc2)cc1.O=C(O)C=CC(=O)O

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 known ✓ P31645 13/20 0.59
MEN1 known ✓ O00255 5/20 0.53
KMT2A known ✓ Q03164 5/20 0.53
SLC6A2 known ✓ P23975 3/20 0.53
MTOR known ✓ P42345 2/20 0.53
HTR2C known ✓ P28335 2/20 0.53
SLC6A3 known ✓ Q01959 2/20 0.53
CHRM2 known ✓ P08172 1/20 0.53
ADRA2A known ✓ P08913 1/20 0.53
DRD2 known ✓ P14416 1/20 0.53
ADRA2B known ✓ P18089 1/20 0.53
CHRM3 known ✓ P20309 1/20 0.53
DRD1 known ✓ P21728 1/20 0.53
HTR2A known ✓ P28223 1/20 0.53
ADRA1A known ✓ P35348 1/20 0.53
HRH1 known ✓ P35367 1/20 0.53
HTR2B known ✓ P41595 1/20 0.53
KCNH2 known ✓ Q12809 1/20 0.53
CACNA1C known ✓ Q13936 1/20 0.53
HRH3 known ✓ Q9Y5N1 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Maleic Acid SCHEMBL9499382 1.00 SLC6A4 (0.59) SLC6A4NOS2MEN1KMT2ACYP2D6
Fluoxetine SCHEMBL6005182 0.81 SLC6A4 (0.82) SLC6A4NOS2MEN1KMT2ACYP2D6
Fluoxetine SCHEMBL6005177 0.81 SLC6A4 (0.82) SLC6A4NOS2MEN1KMT2ACYP2D6
Fluoxetine SCHEMBL27334900 0.81 SLC6A4 (0.82) SLC6A4NOS2MEN1KMT2ACYP2D6
Fluoxetine SCHEMBL27524087 0.80 SLC6A4 (0.80) SLC6A4NOS2MEN1KMT2ACYP2D6
Fluoxetine SCHEMBL5790618 0.80 SLC6A4 (0.82) SLC6A4NOS2MEN1KMT2ACYP2D6
SCHEMBL9499069 0.78 SLC6A4 (0.75) SLC6A4MEN1KMT2ACYP2D6LMNA
Hydrochloric Acid SCHEMBL9500896 0.77 SLC6A4 (0.73) SLC6A4MEN1KMT2ACYP2D6LMNA
SCHEMBL9499388 0.76 SLC6A4 (0.36) SLC6A4NOS2MEN1KMT2ACYP2D6
SCHEMBL8197696 0.76 SLC6A4 (1.00) SLC6A4MEN1KMT2ACYP2D6LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5238959-A For inhibiting serotonin uptake, antidepressant, suppression of alcoholism and obesity ELI LILLY AND COMPANY (US) 1993-08-24 US disclosed
EP-0336753-B1 IMPROVEMENTS IN OR RELATING TO PROPANAMINE DERIVATIVES ELI LILLY AND COMPANY (US) 1992-07-08 EP disclosed
EP-0336753-A1 Improvements in or relating to propanamine derivatives ELI LILLY AND COMPANY (US) 1989-10-11 EP disclosed